课题基金 / 基金详情

项目摘要

项目成果

LEYI GONG的其他基金

相似基金

相关文献

中文摘要
翻译
在美国,近一半的怀孕是意外的。目前迫切需要适合妇女和男子整个生殖生命期需要的生育调节方法。该合同的目的是支持尤尼斯·肯尼迪·施莱佛国家儿童健康和人类发展研究所(NICHD)的使命,通过提供化学筛选和优化设施(CSOF)来确定安全有效的避孕剂,以促进发展,从而开发新的避孕方法。CSOF在生产用于早期体外和体内测试的优化化合物中也具有重要作用。
英文摘要
Nearly half of all pregnancies in the United States are unintended. There is a critical need for fertility regulation methods that fit the needs of women and men throughout their reproductive lives. The objective of this contract is to support the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in its mission to develop novel contraceptive methods by providing a Chemical Screening and Optimization Facility (CSOF) to identify safe and effective contraceptive agents for development. The CSOF also has an important role in the production of optimized compounds for early stage in vitro and in vivo testing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE CORE FUNCTION ACTIVITIES
  • 批准号:
    10942871
  • 项目类别:
  • 资助金额:
    $32.67万
  • 财政年份:
    2023
  • 负责人:
    LEYI GONG
  • 依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - PROTEIN EXPRESSION AND/OR X-RAY CRYSTALLOGRAPHY
  • 批准号:
    10942884
  • 项目类别:
  • 资助金额:
    $26.12万
  • 财政年份:
    2023
  • 负责人:
    LEYI GONG
  • 依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - SCALABLE QUANTITIES
  • 批准号:
    10942882
  • 项目类别:
  • 资助金额:
    $77.32万
  • 财政年份:
    2023
  • 负责人:
    LEYI GONG
  • 依托单位:
Task B28: Efficacy Studies for Therapeutics Development
  • 批准号:
    10703289
  • 项目类别:
  • 资助金额:
    $19.86万
  • 财政年份:
    2022
  • 负责人:
    LEYI GONG
  • 依托单位:
海外基金